S3–02–04: Developing Usp14 inhibitors as disease‐modifying therapeutics for protein aggregation diseases

Autor:	Jyoti Malhotra, Anjanabha Saha, Adriana Villella, Eric Roskelley, Megan Foley, Ken Longo, David Hurtado, Ken Giuliano, Daniel Finley, Brad Tait, Andrés Hurtado-Lorenzo, Mohmmad Hafiz, Markus Haeberlein, James Soper, Dan Garza, Randy King, Eva Nokes, Peter H. Reinhart
Rok vydání:	2013
Předmět:	Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Epidemiology business.industry Health Policy Medicine Neurology (clinical) Disease Geriatrics and Gerontology Protein aggregation Pharmacology business
Zdroj:	Alzheimer's & Dementia. 9
ISSN:	1552-5279 1552-5260
DOI:	10.1016/j.jalz.2013.04.221
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ea1b52cf81842cbed44de04cd7768ddf https://doi.org/10.1016/j.jalz.2013.04.221 Zobrazit plný text záznamu